Every day counts when it comes to access to life-saving medicines. In the EU, an EFPIA - European Federation of Pharmaceutical Industries and Associations report reveals that reducing the time from CHMP recommendation to EMA approval by just 12 days could save 3,300 years of potential life. Behind that number lie untold stories of health restored, connections strengthened, and lives transformed. The cost of delays in medicine approval isn’t just about numbers—it’s about the priceless moments patients and their families lose each day they wait. These delays mean: • Lost moments of independence, well-being, and time with loved ones • Worsening health and emotional strain, impacting entire families • Greater pressure on healthcare systems and higher costs, felt by all • Lost potential for patients to engage in their communities, workplaces, and lives. Let’s work together to reduce these delays and ensure that patients don’t lose precious time—time that could be spent living with dignity, independence, and hope. #HealthcareAccess #PatientAdvocacy #InnovationInHealthcare #healthequity #teameveryone
